fashion -WSS

fashion

author：comprehensive 2025-10-02 18:47:12 - browse：41

One Medical and Amazon Care apps displayed on a phone. -- health tech coverage from STAT. — Adobe

The graveyard is littered with Amazon’s bets in health care: wearables, Care, the ill-fated Haven. Out of their ashes, a new health strategy has emerged at the tech goliath. And while its leaders insist that Amazon has no grand plan for health care, a flurry of moves in the last year offer a glimpse into its ambitions at a time when they seem more cohesive than ever.

“We have learned a lot in the years that we’ve been dabbling in health care,” said Sunita Mishra, chief medical officer for Amazon Health Services. “And it’s now made us more confident that we’re on the right track.”

STAT spoke to four of Amazon’s chief medical officers about the company’s recent plays and how they fit into the company’s health care goals. Last November, it launched Amazon Clinic, a marketplace for virtual-only appointments for straightforward medical needs like pink eye, UTIs, and birth control. Two months later, its Amazon Pharmacy business launched RxPass, a $5 generic medication discount program, setting it up as a Walmart rival. And in February, it closed the acquisition of hybrid primary care company One Medical in a deal valued at $3.9 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Can U.S. cancer drug shortages be fixed?

hotspot

WSS

PBMs are inflating the cost of generic drugs. They must be reined in

Cassava Sciences’ Alzheimer’s clinical trials should be halted

STAT Summit: How researchers deal with rejection

STAT Readout: Friday, Oct. 20 biotech updates

Listen: Vivek Ramaswamy's star turn & leaky drug data

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Wikipedia

fashion

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Roivant's CEO is a star, but biotech's black hole persists

Medical records are filled with copy

As obesity drug market grows, telehealth companies court payers

Anesthesiologist group: stop taking Ozempic before surgery

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Jerome Adams on the need for new antivirals for Covid

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Jerome Adams on the need for new antivirals for Covid

FDA advisory panel to debate high blood pressure devices

focus

Roche drug slashes death risk in early

Questions loom on AstraZeneca cancer drug as safety concerns ebb

STAT Readout: Friday, Oct. 20 biotech updates

Readout LOUD podcast: Live from the 2023 STAT Summit

STAT Summit: The economic case for universal basic health care

Listen: Vivek Ramaswamy's star turn & leaky drug data

hotspot

focus

Wikipedia

explore